| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 569.99B | 506.21B | 322.25B | 292.45B | 192.44B |
| Gross Profit | 44.82B | 28.94B | 21.36B | 29.46B | 34.66B |
| EBITDA | 35.26B | 23.44B | 17.14B | 19.50B | 29.95B |
| Net Income | 24.44B | 14.32B | 24.49B | 10.93B | 18.73B |
Balance Sheet | |||||
| Total Assets | 615.39B | 490.04B | 318.00B | 287.45B | 298.39B |
| Cash, Cash Equivalents and Short-Term Investments | 10.34B | 17.55B | 6.88B | 17.95B | 6.26B |
| Total Debt | 183.20B | 290.42B | 136.82B | 144.85B | 151.70B |
| Total Liabilities | 384.83B | 363.69B | 191.52B | 180.48B | 193.25B |
| Stockholders Equity | 230.56B | 126.30B | 126.48B | 106.96B | 105.14B |
Cash Flow | |||||
| Free Cash Flow | -107.72B | 7.26B | 5.04B | 32.34B | 2.70B |
| Operating Cash Flow | -99.39B | 14.69B | 12.62B | 36.75B | 11.10B |
| Investing Cash Flow | -409.00M | 305.00M | -28.71B | -3.94B | -7.82B |
| Financing Cash Flow | 91.94B | -6.26B | 7.05B | -23.82B | -6.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥201.22B | 22.33 | 11.00% | 2.20% | 6.75% | -0.16% | |
73 Outperform | ¥25.83B | 8.53 | ― | 2.62% | -14.20% | 231.20% | |
72 Outperform | ¥421.05B | 24.29 | ― | 1.30% | 9.57% | 9.73% | |
70 Outperform | ¥5.83B | 6.72 | ― | 1.80% | 4.07% | -20.12% | |
67 Neutral | ¥7.36B | 57.57 | ― | 1.36% | -4.59% | -14.60% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥288.60B | 13.96 | ― | 3.14% | 12.60% | 68.61% |